Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CVNA vs GSK✓SelectedUSD · GSKCVNA vs GSK performance historyLatest closeAs of-2.25%11/16
Stock and ETF performance explorer

CVNA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+17.6%
GSK return
+46.9%
Excess return
-29.3%
Maximum drawdown
-98.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.3%-0.1%-2.2%-2.2%
7D-7.2%-1.3%-5.9%-6.9%
30D+20.2%+2.7%+17.5%+19.5%
3M-6.4%+2.7%-9.1%-7.1%
6M+5.3%+3.3%+2.0%+4.0%
YTD-16.2%+6.5%-22.7%-18.0%
1Y+11.1%+10.7%+0.5%+7.5%
3Y+993.0%+64.4%+928.7%+760.8%
5Y+17.6%+46.7%-29.1%-9.2%
All+17.6%+46.9%-29.3%-9.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling